ZYSTOR THERAPEUTICS INC has a total of 34 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are CELLPEP SA, SAPIENCE THERAPEUTICS INC and GMAX BIOPHARM LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 4 | |
#4 | Israel | 4 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Japan | 2 | |
#9 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Lebowitz Jonathan H | 18 |
#2 | Maga John | 12 |
#3 | Beverley Stephen M | 10 |
#4 | Lebowitz Jonathan | 9 |
#5 | Sly William S | 4 |
#6 | John Maga | 3 |
#7 | Jonathan Lebowitz | 2 |
#8 | Sly Wilian S | 2 |
#9 | Jonathan H Lebowitz | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008063511A2 | Methods for treating pompe disease | |
CN101636200A | Methods for treating pompe disease | |
US2006121018A1 | Methods and compositions for targeting proteins across the blood brain barrier | |
US2005244400A1 | Acid alpha-glucosidase and fragments thereof | |
IL165427D0 | Targeted therapeutic proteins | |
US2005281805A1 | Targeted therapeutic proteins | |
US2004006008A1 | Targeted therapeutic proteins | |
AU2002362930A2 | Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |